One year improvements in cardiovascular risk factors: A comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding

Obesity Surgery

Volumn 20, Issue 5, 2010, Pages 578-582

  Woodard, Gavitt A ^a   Peraza, Joseph ^a   Bravo, Stephanie ^a   Toplosky, Loren ^a   Hernandez Boussard, Tina ^a   Morton, John M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Bariatric surgery; C reactive protein; Cardiovascular risk factors; Cholesterol; Comparative trial; Fasting insulin; Hemoglobin alc; Laparoscopic adjustable gastric banding; Roux en Y gastric bypass; Triglycerides

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GASTRIC BANDING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; BLOOD CHEMICAL ANALYSIS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; GASTRIC BYPASS; GASTROPLASTY; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 77953285263     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-010-0088-0     Document Type: Article

References (30)

1. Kung H, Hoyert D, Xu J, et al. Deaths: Final Data for 2005. National Vital Statistics Report Centers for Disease Control and Prevention 2008; 56(10).
2. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5): 968-977
3. Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 1996; 16(12): 1509-1515
4. Lee IM, Manson JE, Hennekens CH, et al. Body weight and mortality. A 27-year follow-up of middle-aged men. Jama. 1993; 270(23): 2823-2828
5. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995; 333(11):677-685
6. Bleich S, Cutler D, Murray C, et al. Why is the developed world obese? Annu Rev Public Health. 2008; 29: 273-295
7. New CDC Study Finds No Increase in Obesity Among Adults; But Levels Still High. CDC National Center for Health. Statistics 2007, November 28.
8. Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart, attacks? Ann Intern Med. 1999; 130(11): 933-937
9. Braunwald E. Shattuck lecture cardiovascular medicine at the turn, of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997; 337(19): 1360-1369
10. Luc G, Bard JM, Ferneres J, et al. Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Arterioscler Thromb Vase Biol. 2002; 22(7): 1155-1161
11. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997; 337(4): 230-236 (Pubitemid 27310438)
12. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002; 347(20): 1557-1565
13. McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task. Force. Ann Intern Med. 2003; 139(11): 933-949
14. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health, care use in morbidly obese patients. Ann Surg. 2004; 240(3): 416-23. discussion 23-24
15. Brolin RE, Kenler HA, Wilson AC, et al. Serum lipids after gastric bypass surgery for morbid obesity. Int J Obes. 1990; 14 (11): 939-950
16. Nguyen NT, Varela E, Sabio A, et al. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg. 2006; 203(1): 24-29
17. Brolin RE, Bradley LJ, Wilson AC, et al. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg. 2000; 4(5): 464-469
18. Gleysteen JJ, Barboriak JJ. Improvement in heart disease risk factors after gastric bypass. Arch Surg. 1983; 118(6): 681-684
19. Torquati A, Wright K, Melvin W, et al. Effect of gastric bypass operation on Framingham and actual risk of cardiovascular events in class II to III obesity. J Am Coll Surg. 2007; 204(5): 776-82. discussion 82-83
20. Arterburn D, Schauer DP, Wise RE, et al. Change in Predicted 10-Year Cardiovascular Risk Following Laparoscopic Roux-en-Y Gastric Bypass Surgery. Obes Surg 2008.
21. Vogel JA, Franklin BA, Zalesin KC, et al. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol. 2007; 99(2): 222-226
22. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007; 357(8): 753-761
23. Shargorodsky M, Fleed A, Boaz M, et al. The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and. inflammatory parameters in patients with morbid obesity. Int J Obes (Lond). 2006; 30 (11): 1632-1638
24. Dixon JB, O'Brien PE. Lipid, profile in the severely obese: changes with weight loss after lap-band surgery. Obes Res. 2002; 10(9): 903-910
25. Buchwald H, Vareo RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program, on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med. 1990; 323(14): 946-955
26. Buchwald H, Vareo RL, Boen JR, et al. Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial followup report from, the POSCH. Program on the Surgical Control of the Hyperlipidemias. Arch Intern Med. 1998; 158(11): 1253-1261
27. Williams DB, Hagedorn JC, Lawson EH, et al. Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis. 2007; 3(1): 8-13.
28. Weber M, Muller MK, Bucher T, et al. Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg. 2004; 240(6): 975-82. discussion 82-83
29. Batsis JA, Romero-Corral A, Collazo-Clavell ML, et al. Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery. Obesity (Silver Spring). 2007; 15(3): 772-784
30. Levy P, Fried M, Santini F, et al. The comparative effects of bariatric surgery on weight and type 2 diabetes. Obes Surg. 2007; 17(9): 1248-1256